Miguel, JS
41  results:
Search for persons X
?
1

2021 European Myeloma Network review and consensus statemen..:

Musto, P ; Engelhardt, M ; Caers, J...
Haematologica: the hematology journal, 2021, 106 (11), pp. 2799 - 2812.  , 2022
 
?
3

Treatment of relapsed and refractory multiple myeloma: reco..:

Moreau, P ; Kumar, SK ; Miguel, JS...
https://discovery.ucl.ac.uk/id/eprint/10125552/1/IMWG_relapse_V6_AUGUST_8_2020.pdf.  , 2021
 
?
4

International Myeloma Working Group guidelines for serum-fr..:

Dispenzieri A ; Kyle R ; Merlini G...
info:eu-repo/semantics/altIdentifier/wos/WOS:000263312300001.  , 2009
 
?
11

Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970..:

Yap, TA ; O'Carrigan, B ; Penney, MS...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 38 (27), pp. 3195 - 3204.  , 2020
 
?
12

Daratumumab, lenalidomide, and dexamethasone in relapsed/re..:

Kaufman, JL ; Dimopoulos, MA ; White, D...
https://eprints.whiterose.ac.uk/168243/1/Kaufman.POLLUX%20Cyto%20Risk.BCJ.2020.pdf.  , 2020
 
?
14

Pooled analysis of WHO Surgical Safety Checklist use and mo..:

Thomas, HS ; Weiser, TG ; Drake, TM...
https://openaccess.sgul.ac.uk/id/eprint/110662/1/Collaborative-2019-British_Journal_of_Surgery.pdf.  , 2019
 
?
15

Pooled analysis of WHO Surgical Safety Checklist use and mo..:

Thomas, HS ; Weiser, TG ; Drake, TM...
https://discovery.ucl.ac.uk/id/eprint/10067274/1/Collaborative-2019-British_Journal_of_Surgery.pdf.  , 2019
 
1-15